ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter

Kyoto University to start providing Embryonic Stem cells for clinical studies

The move, a first for Japan, will widen applications of regenerative medicine

KYOTO, Japan -- Kyoto University said Tuesday it will start providing human embryonic stem cells by July to colleges and private companies for clinical trials. The cells, like induced pluripotent stem cells, can create various types of organs and tissues.

The move is expected to help expand ES cell studies in the country, and lead to wider application of regenerative medicine.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Discover the all new Nikkei Asia app

  • Take your reading anywhere with offline reading functions
  • Never miss a story with breaking news alerts
  • Customize your reading experience

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more